EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieVergleichsstudie

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling

Thibaut Long-Depaquit, Michael Baboudjian, Arthur Peyrottes, Alessandro Uleri, Julien Anract, Frederica Sordelli, Luc Brabant, Grégoire Assenmacher, Francesco Sanguedolce, Gaëlle Fiard, Maya Louni, Raphaële Renard-Penna und 10 weitere

European Urology Focus · 2026-10 · 12 (5) · 924-930

DOI: 10.1016/j.euf.2026.04.016 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Urology Focus, 2026-10. Verfasst von Thibaut Long-Depaquit und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, North Hospital, Aix-Marseille University, AP-HM, Marseille, France; Aix Marseille Univ, CNRS, CINAM, ERL INSERM U 1326, CERIME…. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Magnetic Resonance Imaging, Interventional, Prostate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: The transperineal (TP) route is recommended for prostate biopsy due to its superior safety profile. However, randomized evidence comparing the TP and the transrectal (TR) routes was generated through combined targeted and systematic biopsy frameworks, now challenged by lesion-focused strategies, defined as the combination of targeted (TB) and perilesional (PB) sampling without distant systematic cores. This study aimed to reassess the diagnostic performance of TP versus TR biopsy with the recommended TB + PB scheme. METHODS: This prospective multicenter, observational study was conducted across 10 European institutions between January 2025 and June 2025. We included 912 men with at least one magnetic resonance imaging (MRI)-visible lesion (Prostate Imaging-Reporting and Data System version 2.1 ≥3) who underwent either TP or TR MRI-targeted biopsy according to predefined TB + PB protocols. The primary outcome was the detection rate of clinically significant prostate cancer (csPC; Gleason Grade [GG] Group ≥2). KEY FINDINGS AND LIMITATIONS: TP biopsy detected more csPC than TR (48% vs 39%; OR [odds ratio]: 1.41, 95% CI [confidence interval]: 1.06-1.88; p = 0.017) without increasing the detection of insignificant PC (insPC) (18% vs 23%; p = 0.06). In multivariable mixed-effects analysis accounting for center-level clustering, the TP route remained independently associated with csPC detection (adjusted OR: 1.61, 95% CI: 1.17-2.23; p = 0.004). Limitations include limited power in selected subgroups and potential inter-center heterogeneity inherent to the observational design. CONCLUSIONS AND CLINICAL IMPLICATIONS: Within a standardized lesion-focused TB + PB framework, TP biopsy was independently associated with higher csPC detection without increasing insPC detection. This study focuses on diagnostic performance and does not provide direct comparative data on biopsy-related complications or patient-reported outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Image-Guided BiopsyMagnetic Resonance Imaging, InterventionalProstateAgedHumansMaleMiddle AgedMagnetic Resonance ImagingNeoplasm GradingPerineumProspective StudiesProstatic NeoplasmsRectum

Stichwörter der Autor:innen

Distant biopsyPI-RADSProstate cancerRegional biopsyTargeted biopsy

Autor:innen und Institutionen

  • Department of Urology, North Hospital, Aix-Marseille University, AP-HM, Marseille, France; Aix Marseille Univ, CNRS, CINAM, ERL INSERM U 1326, CERIMED, Marseille, France. Electronic address: Thibaut.long2@gmail.com.
  • Department of Urology, North Hospital, Aix-Marseille University, AP-HM, Marseille, France; Aix Marseille Univ, CNRS, CINAM, ERL INSERM U 1326, CERIMED, Marseille, France.
  • Department of Urology, La Croix du Sud Hospital, Quint-Fonsegrives, France.
  • Department of Urology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.
  • Department of Urology, Hôpital Cochin, AP-HP, Paris, France.
  • Department of Urology, Europe Hospitals, Ste-Elisabeth, Brussels, Belgium.

Zitieren

APA

Long-Depaquit, T., Baboudjian, M., Peyrottes, A., Uleri, A., Anract, J., Sordelli, F., Brabant, L., Assenmacher, G., Sanguedolce, F., Fiard, G., Louni, M., Renard-Penna, R., Hubner, N., Messas, A., Windisch, O., Toledano, H., Corral, R., Colinet, V., Bastide, C., …, & Diamand, R. (2026). Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling. European Urology Focus, 12(5), 924-930. https://doi.org/10.1016/j.euf.2026.04.016

Vancouver

Long-Depaquit T, Baboudjian M, Peyrottes A, Uleri A, Anract J, Sordelli F, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling. European Urology Focus. 2026;12(5):924-930. doi:10.1016/j.euf.2026.04.016

BibTeX
@article{LongDepaquit2026,
  author = {Long-Depaquit, Thibaut and Baboudjian, Michael and Peyrottes, Arthur and Uleri, Alessandro and Anract, Julien and Sordelli, Frederica and Brabant, Luc and Assenmacher, Grégoire and Sanguedolce, Francesco and Fiard, Gaëlle and Louni, Maya and Renard-Penna, Raphaële and Hubner, Nicolai and Messas, Aurel and Windisch, Olivier and Toledano, Harry and Corral, Renaud and Colinet, Valentin and Bastide, Cyrille and Peltier, Alexandre and Ploussard, Guillaume and Diamand, Romain},
  title = {Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling},
  journal = {European Urology Focus},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {924--930},
  doi = {10.1016/j.euf.2026.04.016}
}
Kostenlos starten →